Page last updated: 2024-08-23

raloxifene hydrochloride and Vitamin D Deficiency

raloxifene hydrochloride has been researched along with Vitamin D Deficiency in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (66.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adami, S; Bianchi, G; Di Munno, O; Fiore, CE; Giannini, S; Minisola, S; Rossini, M; Sinigaglia, L	1
McDermott, MT; Minne, P; Vondracek, SF	1
Frassetto, LA; Gordon, PL	1
Jerums, G; MacIsaac, RJ; Seeman, E; Varadarajan, S; Vu, TD	1
Antoniucci, DM; Black, DM; Blackwell, T; Sellmeyer, DE; Vittinghoff, E	1
Chesnut, CH; Gass, ML; Hamdy, RC; Holick, MF; Leib, ES; Lewiecki, ME; Maricic, M; Watts, NB	1

Reviews

3 review(s) available for raloxifene hydrochloride and Vitamin D Deficiency

Article	Year
Clinical challenges in the management of osteoporosis. Clinical interventions in aging, 2008, Volume: 3, Issue:2 Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combination; Female; Humans; Osteoporosis; Raloxifene Hydrochloride; Vitamin D; Vitamin D Deficiency	2008
Management of osteoporosis in CKD Stages 3 to 5. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010, Volume: 55, Issue:5 Topics: Absorptiometry, Photon; Accidental Falls; Aged; Animals; Bone Density; Bone Density Conservation Agents; Calcitonin; Comorbidity; Diphosphonates; Female; Glomerular Filtration Rate; Humans; Life Style; Magnetic Resonance Imaging; Muscle Strength; Nandrolone; Nandrolone Decanoate; Nitric Oxide; Osteoporosis; Parathyroid Hormone; Phosphates; Raloxifene Hydrochloride; Renal Insufficiency, Chronic; Selective Estrogen Receptor Modulators; Teriparatide; Tomography, X-Ray Computed; Vitamin D Deficiency	2010
Review of treatment modalities for postmenopausal osteoporosis. Southern medical journal, 2005, Volume: 98, Issue:10 Topics: Alendronate; Bone Density; Bone Density Conservation Agents; Calcium; Combined Modality Therapy; Diet; Dietary Supplements; Diphosphonates; Etidronic Acid; Exercise; Female; Fish Oils; Hip Fractures; Humans; Ibandronic Acid; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risedronic Acid; Teriparatide; Vitamin D; Vitamin D Deficiency	2005

Trials

1 trial(s) available for raloxifene hydrochloride and Vitamin D Deficiency

Article	Year
Vitamin D insufficiency does not affect bone mineral density response to raloxifene. The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:8 Topics: Aged; Bone Density; Drug Interactions; Estrogen Antagonists; Humans; Incidence; Middle Aged; Osteoporosis; Postmenopause; Raloxifene Hydrochloride; Spinal Fractures; Vitamin D; Vitamin D Deficiency	2005

Other Studies

2 other study(ies) available for raloxifene hydrochloride and Vitamin D Deficiency

Article	Year
Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2009, Volume: 20, Issue:2 Topics: Activities of Daily Living; Aged; Alendronate; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Resorption; Calcium; Confounding Factors, Epidemiologic; Dietary Supplements; Etidronic Acid; Female; Fractures, Bone; Humans; Incidence; Logistic Models; Middle Aged; Odds Ratio; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Retrospective Studies; Risedronic Acid; Risk; Treatment Outcome; Vitamin D; Vitamin D Deficiency	2009
Hypocalcemia induced by raloxifene. Current drug safety, 2012, Volume: 7, Issue:2 Topics: Aged, 80 and over; Bone Density Conservation Agents; Female; Humans; Hypocalcemia; Mass Screening; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Vitamin D Deficiency	2012

Article

Year

Vitamin D status and response to treatment in post-menopausal osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2009, Volume: 20, Issue:2

Topics: Activities of Daily Living; Aged; Alendronate; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Resorption; Calcium; Confounding Factors, Epidemiologic; Dietary Supplements; Etidronic Acid; Female; Fractures, Bone; Humans; Incidence; Logistic Models; Middle Aged; Odds Ratio; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Retrospective Studies; Risedronic Acid; Risk; Treatment Outcome; Vitamin D; Vitamin D Deficiency

2009

Hypocalcemia induced by raloxifene.

Current drug safety, 2012, Volume: 7, Issue:2

Topics: Aged, 80 and over; Bone Density Conservation Agents; Female; Humans; Hypocalcemia; Mass Screening; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Vitamin D Deficiency

2012